Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.530
-0.130 (-4.89%)
At close: Feb 21, 2025, 4:00 PM
2.580
+0.050 (1.98%)
After-hours: Feb 21, 2025, 7:50 PM EST
Evaxion Biotech Employees
Evaxion Biotech had 49 employees as of December 31, 2023. The number of employees decreased by 14 or -22.22% compared to the previous year.
Employees
49
Change (1Y)
-14
Growth (1Y)
-22.22%
Revenue / Employee
$67,245
Profits / Employee
-$233,898
Market Cap
15.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | 35 | -1 | -2.78% |
| Dec 31, 2019 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
EVAX News
- 22 days ago - Evaxion announces closing of $10.8 million public offering - GlobeNewsWire
- 23 days ago - Evaxion announces pricing of $10.8 million public offering - GlobeNewsWire
- 25 days ago - Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement - GlobeNewsWire
- 5 weeks ago - Evaxion announces completion of ADS ratio change - GlobeNewsWire
- 6 weeks ago - Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change - GlobeNewsWire
- 7 weeks ago - Evaxion announces plan to implement ADS ratio change - GlobeNewsWire
- 3 months ago - Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewsWire
- 4 months ago - Evaxion announces business update and third quarter 2024 financial results - GlobeNewsWire